Published in JAMA on June 27, 2007
Treating childhood acute lymphoblastic leukemia without cranial irradiation. N Engl J Med (2009) 7.95
Clinical ascertainment of health outcomes among adults treated for childhood cancer. JAMA (2013) 3.65
Medical care in long-term survivors of childhood cancer: a report from the childhood cancer survivor study. J Clin Oncol (2008) 3.27
Prospective medical assessment of adults surviving childhood cancer: study design, cohort characteristics, and feasibility of the St. Jude Lifetime Cohort study. Pediatr Blood Cancer (2010) 2.69
Morbidity and mortality in long-term survivors of Hodgkin lymphoma: a report from the Childhood Cancer Survivor Study. Blood (2010) 2.58
Aging and risk of severe, disabling, life-threatening, and fatal events in the childhood cancer survivor study. J Clin Oncol (2014) 2.45
Breast cancer surveillance practices among women previously treated with chest radiation for a childhood cancer. JAMA (2009) 2.42
A model-based estimate of cumulative excess mortality in survivors of childhood cancer. Ann Intern Med (2010) 2.28
Chronic disease in the Childhood Cancer Survivor Study cohort: a review of published findings. J Clin Oncol (2009) 2.23
Systematic review: surveillance for breast cancer in women treated with chest radiation for childhood, adolescent, or young adult cancer. Ann Intern Med (2010) 2.17
Long-term outcomes in survivors of neuroblastoma: a report from the Childhood Cancer Survivor Study. J Natl Cancer Inst (2009) 2.03
General internists' preferences and knowledge about the care of adult survivors of childhood cancer: a cross-sectional survey. Ann Intern Med (2014) 2.03
Modifiable risk factors and major cardiac events among adult survivors of childhood cancer. J Clin Oncol (2013) 1.83
Testicular cancer survivorship: research strategies and recommendations. J Natl Cancer Inst (2010) 1.76
Assessment of dexrazoxane as a cardioprotectant in doxorubicin-treated children with high-risk acute lymphoblastic leukaemia: long-term follow-up of a prospective, randomised, multicentre trial. Lancet Oncol (2010) 1.52
A worldwide collaboration to harmonize guidelines for the long-term follow-up of childhood and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group. Pediatr Blood Cancer (2012) 1.49
Increasing rates of breast cancer and cardiac surveillance among high-risk survivors of childhood Hodgkin lymphoma following a mailed, one-page survivorship care plan. Pediatr Blood Cancer (2010) 1.44
Ionizing radiation-induced long-term expression of senescence markers in mice is independent of p53 and immune status. Aging Cell (2010) 1.43
Differences in activities of daily living performance between long-term pediatric sarcoma survivors and a matched comparison group on standardized testing. Pediatr Blood Cancer (2009) 1.41
Long-term survivors of childhood Ewing sarcoma: report from the childhood cancer survivor study. J Natl Cancer Inst (2010) 1.38
Insulin resistance and risk factors for cardiovascular disease in young adult survivors of childhood acute lymphoblastic leukemia. J Clin Oncol (2009) 1.36
Childhood cancer survivors, late effects, and a new model for understanding survivorship. JAMA (2007) 1.28
Yield of screening for long-term complications using the children's oncology group long-term follow-up guidelines. J Clin Oncol (2012) 1.26
Burden of illness in adult survivors of childhood cancers: findings from a population-based national sample. Cancer (2010) 1.26
Hospitalization rates among survivors of childhood cancer in the Childhood Cancer Survivor Study cohort. Pediatr Blood Cancer (2011) 1.16
The isolation and characterization of renal cancer initiating cells from human Wilms' tumour xenografts unveils new therapeutic targets. EMBO Mol Med (2012) 1.15
Somatic mutations in DROSHA and DICER1 impair microRNA biogenesis through distinct mechanisms in Wilms tumours. Nat Commun (2014) 1.12
Wilms tumor--a renal stem cell malignancy? Pediatr Nephrol (2011) 1.11
Imaging findings in noncraniofacial childhood rhabdomyosarcoma. Pediatr Radiol (2008) 1.09
Induction of antiproliferative connective tissue growth factor expression in Wilms' tumor cells by sphingosine-1-phosphate receptor 2. Mol Cancer Res (2008) 1.06
Survivorship programs and care plans in practice: variations on a theme. J Oncol Pract (2011) 1.01
Follow-up care for cancer survivors: views of the younger adult. Br J Cancer (2009) 0.98
Family doctor-driven follow-up for adult childhood cancer survivors supported by a web-based survivor care plan. J Cancer Surviv (2011) 0.97
Impact of survivorship-based research on defining clinical care guidelines. Cancer Epidemiol Biomarkers Prev (2011) 0.97
Contribution of diet and physical activity to metabolic parameters among survivors of childhood leukemia. Cancer Causes Control (2012) 0.95
American Society of Clinical Oncology policy statement update: the critical role of phase I trials in cancer research and treatment. J Clin Oncol (2014) 0.90
Long-term adverse effects of hematopoietic stem cell transplantation on dental development in children. Support Care Cancer (2009) 0.87
Targeted therapy aimed at cancer stem cells: Wilms' tumor as an example. Pediatr Nephrol (2013) 0.87
Disseminating a smoking cessation intervention to childhood and young adult cancer survivors: baseline characteristics and study design of the partnership for health-2 study. BMC Cancer (2011) 0.87
Alpe d'HuZes cancer rehabilitation (A-CaRe) research: four randomized controlled exercise trials and economic evaluations in cancer patients and survivors. Int J Behav Med (2012) 0.87
Canadian Study of Determinants of Endometabolic Health in ChIlDrEn (CanDECIDE study): a cohort study protocol examining the mechanisms of obesity in survivors of childhood brain tumours. BMJ Open (2013) 0.86
Response to a treatment summary and care plan among adult survivors of pediatric and young adult cancer. J Oncol Pract (2012) 0.85
Understanding the functional late effects and informational needs of adult survivors of childhood cancer. Oncol Nurs Forum (2013) 0.84
Long term cause specific mortality among 34 489 five year survivors of childhood cancer in Great Britain: population based cohort study. BMJ (2016) 0.84
Reproductive late effects in female survivors of childhood cancer. Obstet Gynecol Int (2012) 0.83
Second cancers after childhood cancer--GPs beware! Scand J Prim Health Care (2013) 0.83
Evaluation of a patient information website for childhood cancer survivors. Support Care Cancer (2012) 0.83
NCI, NHLBI first international consensus conference on late effects after pediatric hematopoietic cell transplantation: state of the science, future directions. Biol Blood Marrow Transplant (2011) 0.83
Events in Early Life are Associated with Female Reproductive Ageing: A UK Biobank Study. Sci Rep (2016) 0.82
Educational paper: decreasing the burden of cardiovascular disease in childhood cancer survivors: an update for the pediatrician. Eur J Pediatr (2013) 0.82
Collaborative Research in Childhood Cancer Survivorship: The Current Landscape. J Clin Oncol (2015) 0.82
Secretion of SDF-1alpha by bone marrow-derived stromal cells enhances skin wound healing of C57BL/6 mice exposed to ionizing radiation. J Cell Mol Med (2009) 0.81
Patterns of physician follow-up among young cancer survivors: report of the Childhood, Adolescent, and Young Adult Cancer Survivors (CAYACS) research program. Can Fam Physician (2011) 0.81
Psychometric properties of KIDSCREEN-27 among childhood cancer survivors and age matched peers: a Rasch analysis. Health Qual Life Outcomes (2013) 0.81
Renal dysfunction and elevated blood pressure in long-term childhood cancer survivors. Clin J Am Soc Nephrol (2012) 0.81
Renal tumours: long-term outcome. Pediatr Nephrol (2011) 0.81
Decline in physical activity level in the Childhood Cancer Survivor Study cohort. Cancer Epidemiol Biomarkers Prev (2014) 0.81
Interleukin 18 as a marker of chronic nephropathy in children after anticancer treatment. Dis Markers (2013) 0.81
Follow-up programs for childhood cancer survivors in Europe: a questionnaire survey. PLoS One (2012) 0.80
Health media use among childhood and young adult cancer survivors who smoke. Support Care Cancer (2014) 0.80
Neurocognitive Late Effects of Chemotherapy in Survivors of Acute Lymphoblastic Leukemia: Focus on Methotrexate. J Can Acad Child Adolesc Psychiatry (2015) 0.80
Childhood cancer survivors' familiarity with and opinions of the Patient Protection and Affordable Care Act. J Oncol Pract (2013) 0.80
Identifying Predictors of Longitudinal Decline in the Level of Medical Care Received by Adult Survivors of Childhood Cancer: A Report from the Childhood Cancer Survivor Study. Health Serv Res (2015) 0.79
Oral and dental late effects in survivors of childhood cancer: a Children's Oncology Group report. Support Care Cancer (2014) 0.79
Follow-up of children who survive cancer. BMJ (2008) 0.79
Explorative study on the aftercare of pediatric brain tumor survivors: a parents' perspective. Support Care Cancer (2010) 0.79
Using three legacy measures to develop a health-related quality of life tool for young adult survivors of childhood cancer. Qual Life Res (2011) 0.79
Increased uptake of social security benefits among long-term survivors of cancer in childhood, adolescence and young adulthood: a Norwegian population-based cohort study. Br J Cancer (2013) 0.79
In search of targeted therapies for childhood cancer. Front Oncol (2011) 0.79
Studying Hospitalizations and Mortality in the Netherlands: Feasible and Valid Using Two-Step Medical Record Linkage with Nationwide Registers. PLoS One (2015) 0.78
A new method to facilitate valid and consistent grading cardiac events in childhood cancer survivors using medical records. PLoS One (2014) 0.78
Reproduction and marriage among male survivors of cancer in childhood, adolescence and young adulthood: a national cohort study. Br J Cancer (2016) 0.78
Increasing and worsening late effects in childhood cancer survivors during follow-up. J Korean Med Sci (2013) 0.78
The effectiveness of interventions to treat obesity in survivors of childhood brain tumors: a systematic review protocol. Syst Rev (2016) 0.78
Frailty in childhood cancer survivors. Cancer (2014) 0.78
Tobacco use and exposure among youth undergoing cancer treatment. J Pediatr Health Care (2014) 0.77
The Second Pediatric Blood and Marrow Transplant Consortium International Consensus Conference on Late Effects after Pediatric Hematopoietic Cell Transplantation: Defining the Unique Late Effects of Children Undergoing Hematopoietic Cell Transplantation for Immune Deficiencies, Inherited Marrow Failure Disorders, and Hemoglobinopathies. Biol Blood Marrow Transplant (2016) 0.77
Approach for Classification and Severity-grading of Long-term and Late-onset Health Events among Childhood Cancer Survivors in the St. Jude Lifetime Cohort. Cancer Epidemiol Biomarkers Prev (2016) 0.77
Cardiorespiratory fitness and physical activity in children with cancer. Support Care Cancer (2015) 0.77
Health-related quality of life and cognitive outcomes among child and adolescent survivors of leukemia. Support Care Cancer (2009) 0.76
Radiation-Related New Primary Solid Cancers in the Childhood Cancer Survivor Study: Comparative Radiation Dose Response and Modification of Treatment Effects. Int J Radiat Oncol Biol Phys (2015) 0.76
High Hospitalization Rates in Survivors of Childhood Cancer: A Longitudinal Follow-Up Study Using Medical Record Linkage. PLoS One (2016) 0.76
Survival of patients who develop solid tumors following hematopoietic stem cell transplantation. Bone Marrow Transplant (2015) 0.76
Imaging of acute and subacute toxicities of cancer therapy in children. Pediatr Radiol (2015) 0.76
Childhood cancer, endocrine disorders, and cohort studies. Lancet (2014) 0.75
The Initiative to Maximize Progress in Adolescent and Young Adult Cancer Therapy (IMPACT) Cohort Study: a population-based cohort of young Canadians with cancer. BMC Cancer (2014) 0.75
Evaluating Early Case Capture of Pediatric Cancers in Seven Central Cancer Registries in the United States, 2013. Public Health Rep (2016) 0.75
Media Use and the Cancer Communication Strategies of Cancer Survivors. J Cancer Prev (2016) 0.75
Observed magnetic resonance imaging changes in pediatric patients treated with stereotactic radiosurgery for intracranial tumors. Childs Nerv Syst (2010) 0.75
Non-oncology physician visits after diagnosis of cancer in children. BMC Fam Pract (2016) 0.75
Dental Anomalies as Late Adverse Effect among Young Children Treated for Cancer. Cancer Res Treat (2015) 0.75
Increased health care utilization by survivors of childhood lymphoblastic leukemia is confined to those treated with cranial or total body irradiation: a case cohort study. BMC Cancer (2014) 0.75
Editorial on the role of "Genetic mediators of neurocognitive outcome in survivors of childhood acute lymphoblastic leukemia". Transl Pediatr (2013) 0.75
Aspects of mental health dysfunction among survivors of childhood cancer. Br J Cancer (2015) 0.75
Barriers and Facilitators of Healthy Diet and Exercise Among Adolescent and Young Adult Cancer Survivors: Implications for Behavioral Interventions. J Adolesc Young Adult Oncol (2015) 0.75
A Concise and Practical Framework for the Development and Usability Evaluation of Patient Information Websites. Appl Clin Inform (2015) 0.75
Gene expression profiling predicts clinical outcome of breast cancer. Nature (2002) 71.36
A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med (2002) 58.15
Histone deacetylases (HDACs): characterization of the classical HDAC family. Biochem J (2003) 11.27
Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features. PLoS One (2008) 5.86
Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. J Natl Cancer Inst (2010) 4.54
Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes. Nature (2012) 4.53
The results of surgical excision and adjuvant irradiation for therapy-resistant keloids: a prospective clinical outcome study. Plast Reconstr Surg (2007) 4.10
Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease. JAMA (2003) 4.01
Physical activity and breast cancer: a systematic review. Epidemiology (2007) 3.90
Long-term risk of cardiovascular disease in 10-year survivors of breast cancer. J Natl Cancer Inst (2007) 3.55
Long-term cause-specific mortality of patients treated for Hodgkin's disease. J Clin Oncol (2003) 3.24
Anaplastic large-cell lymphoma in women with breast implants. JAMA (2008) 3.23
Incidence of retinoblastoma in children born after in-vitro fertilisation. Lancet (2003) 3.22
Risk of second malignancies in survivors of retinoblastoma: more than 40 years of follow-up. J Natl Cancer Inst (2008) 3.13
Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma. J Natl Cancer Inst (2005) 3.07
Clinical heart failure in a cohort of children treated with anthracyclines: a long-term follow-up study. Eur J Cancer (2006) 2.99
Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer. J Clin Oncol (2007) 2.68
Second malignant neoplasms among long-term survivors of Hodgkin's disease: a population-based evaluation over 25 years. J Clin Oncol (2002) 2.63
Increased risk of stroke and transient ischemic attack in 5-year survivors of Hodgkin lymphoma. J Natl Cancer Inst (2009) 2.55
Exposure to diagnostic radiation and risk of breast cancer among carriers of BRCA1/2 mutations: retrospective cohort study (GENE-RAD-RISK). BMJ (2012) 2.44
Lung cancer following chemotherapy and radiotherapy for Hodgkin's disease. J Natl Cancer Inst (2002) 2.44
Breast cancer risk in female survivors of Hodgkin's lymphoma: lower risk after smaller radiation volumes. J Clin Oncol (2009) 2.42
Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk. PLoS Genet (2013) 2.39
Nephron sparing surgery (NSS) for unilateral wilms tumor (UWT): the SIOP 2001 experience. Pediatr Blood Cancer (2014) 2.28
Breast cancer survival and tumor characteristics in premenopausal women carrying the CHEK2*1100delC germline mutation. J Clin Oncol (2006) 2.28
Impact of pathological characteristics on local relapse after breast-conserving therapy: a subgroup analysis of the EORTC boost versus no boost trial. J Clin Oncol (2009) 2.26
Late cardiotoxicity after treatment for Hodgkin lymphoma. Blood (2006) 2.18
Predictors of the rate of decline of residual renal function in incident dialysis patients. Kidney Int (2002) 2.12
Hypospadias in sons of women exposed to diethylstilbestrol in utero: a cohort study. Lancet (2002) 2.10
The think aloud method: a guide to user interface design. Int J Med Inform (2004) 2.09
A protocol for building and evaluating predictors of disease state based on microarray data. Bioinformatics (2005) 2.08
Potential for bias in studies on efficacy of prophylactic surgery for BRCA1 and BRCA2 mutation. J Natl Cancer Inst (2003) 2.02
Hyperfractionated versus conventional radiotherapy followed by chemotherapy in standard-risk medulloblastoma: results from the randomized multicenter HIT-SIOP PNET 4 trial. J Clin Oncol (2012) 2.01
LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression. Nat Genet (2012) 1.96
Cross-validated Cox regression on microarray gene expression data. Stat Med (2006) 1.90
Cardiac function in 5-year survivors of childhood cancer: a long-term follow-up study. Arch Intern Med (2010) 1.87
High incidence of malformation syndromes in a series of 1,073 children with cancer. Am J Med Genet A (2005) 1.85
Oral contraceptives and breast cancer risk in the international BRCA1/2 carrier cohort study: a report from EMBRACE, GENEPSO, GEO-HEBON, and the IBCCS Collaborating Group. J Clin Oncol (2007) 1.83
Expression profiling predicts outcome in breast cancer. Breast Cancer Res (2002) 1.81
A prospective study on drug monitoring of PEGasparaginase and Erwinia asparaginase and asparaginase antibodies in pediatric acute lymphoblastic leukemia. Blood (2014) 1.80
Increased risk of ischemic stroke after radiotherapy on the neck in patients younger than 60 years. J Clin Oncol (2002) 1.79
Risk of new primary nonbreast cancers after breast cancer treatment: a Dutch population-based study. J Clin Oncol (2008) 1.76
Testicular cancer survivorship: research strategies and recommendations. J Natl Cancer Inst (2010) 1.76
Second Cancer Risk Up to 40 Years after Treatment for Hodgkin's Lymphoma. N Engl J Med (2015) 1.70
Predicting a local recurrence after breast-conserving therapy by gene expression profiling. Breast Cancer Res (2006) 1.69
Protecting against anthracycline-induced myocardial damage: a review of the most promising strategies. Br J Haematol (2005) 1.68
Accelerated aging, decreased white matter integrity, and associated neuropsychological dysfunction 25 years after pediatric lymphoid malignancies. J Clin Oncol (2013) 1.67
Inactivation of CDK2 is synthetically lethal to MYCN over-expressing cancer cells. Proc Natl Acad Sci U S A (2009) 1.66
Molecular classification of breast carcinomas by comparative genomic hybridization: a specific somatic genetic profile for BRCA1 tumors. Cancer Res (2002) 1.64
Pharmacogenomic prediction of anthracycline-induced cardiotoxicity in children. J Clin Oncol (2011) 1.62
Detecting minimal residual disease in neuroblastoma: the superiority of a panel of real-time quantitative PCR markers. Clin Chem (2009) 1.62
Malignant mesothelioma after radiation treatment for Hodgkin lymphoma. Blood (2009) 1.57
Impact of mammographic screening on the detection of good and poor prognosis breast cancers. Breast Cancer Res Treat (2011) 1.55
Long-term risk of cardiovascular disease in 5-year survivors of testicular cancer. J Clin Oncol (2006) 1.55
High risk of symptomatic cardiac events in childhood cancer survivors. J Clin Oncol (2012) 1.53
Cyclin D1 and CDK4 activity contribute to the undifferentiated phenotype in neuroblastoma. Cancer Res (2008) 1.50
Rectal bleeding, fecal incontinence, and high stool frequency after conformal radiotherapy for prostate cancer: normal tissue complication probability modeling. Int J Radiat Oncol Biol Phys (2006) 1.50
A worldwide collaboration to harmonize guidelines for the long-term follow-up of childhood and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group. Pediatr Blood Cancer (2012) 1.49
[Contribution of lifestyle factors to cancer: secondary analysis of Dutch data over 2010 and a projection for 2020]. Ned Tijdschr Geneeskd (2014) 1.46
The number of retrieved oocytes does not decrease during consecutive gonadotrophin-stimulated IVF cycles. Hum Reprod (2004) 1.46
Accuracy of internal mammary lymph node localization using lymphoscintigraphy, sonography and CT. Radiother Oncol (2002) 1.45
Anti-Mullerian hormone is a sensitive serum marker for gonadal function in women treated for Hodgkin's lymphoma during childhood. J Clin Endocrinol Metab (2007) 1.42
Observer variation in target volume delineation of lung cancer related to radiation oncologist-computer interaction: a 'Big Brother' evaluation. Radiother Oncol (2005) 1.39
Cause-specific mortality in long-term survivors of breast cancer: A 25-year follow-up study. Int J Radiat Oncol Biol Phys (2006) 1.39
Roles of radiation dose and chemotherapy in the etiology of stomach cancer as a second malignancy. Int J Radiat Oncol Biol Phys (2009) 1.36
Cardiometabolic differences in children born after in vitro fertilization: follow-up study. J Clin Endocrinol Metab (2008) 1.36
Physical activity and endometrial cancer risk, a systematic review of current evidence. Cancer Epidemiol Biomarkers Prev (2007) 1.35
Cardioprotective interventions for cancer patients receiving anthracyclines. Cochrane Database Syst Rev (2011) 1.31
Leukemia and brain tumors among children after radiation exposure from CT scans: design and methodological opportunities of the Dutch Pediatric CT Study. Eur J Epidemiol (2014) 1.30
Five polymorphisms and breast cancer risk: results from the Breast Cancer Association Consortium. Cancer Epidemiol Biomarkers Prev (2009) 1.29
Different dosage schedules for reducing cardiotoxicity in cancer patients receiving anthracycline chemotherapy. Cochrane Database Syst Rev (2009) 1.28
Long-term risk of cardiovascular disease after treatment for aggressive non-Hodgkin lymphoma. Blood (2005) 1.28
Association of C-MYC amplification with progression from the in situ to the invasive stage in C-MYC-amplified breast carcinomas. J Pathol (2003) 1.27
Reproductive and hormonal factors, and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers: results from the International BRCA1/2 Carrier Cohort Study. Cancer Epidemiol Biomarkers Prev (2009) 1.25
Challenges after curative treatment for childhood cancer and long-term follow up of survivors. Pediatr Clin North Am (2008) 1.24
CPOE system design aspects and their qualitative effect on usability. Stud Health Technol Inform (2008) 1.24
Independent prognostic value of screen detection in invasive breast cancer. J Natl Cancer Inst (2011) 1.23
The role of genetic breast cancer susceptibility variants as prognostic factors. Hum Mol Genet (2012) 1.23
Antibiotic prophylaxis for bacterial infections in afebrile neutropenic patients following chemotherapy. Cochrane Database Syst Rev (2012) 1.22
Body weight and risk of breast cancer in BRCA1/2 mutation carriers. Breast Cancer Res Treat (2010) 1.22
Prognostic factors for progression of childhood optic pathway glioma: a systematic review. Eur J Cancer (2006) 1.22
Rearrangements and increased expression of cyclin D1 (CCND1) in neuroblastoma. Genes Chromosomes Cancer (2003) 1.21
Stomach cancer risk after treatment for hodgkin lymphoma. J Clin Oncol (2013) 1.21
Detection of circulating breast tumor cells by differential expression of marker genes. Clin Cancer Res (2002) 1.20
Different anthracycline derivates for reducing cardiotoxicity in cancer patients. Cochrane Database Syst Rev (2010) 1.20
Excess risk for contralateral breast cancer in CHEK2*1100delC germline mutation carriers. Breast Cancer Res Treat (2004) 1.19
Prevalence and patterns of morphological abnormalities in patients with childhood cancer. JAMA (2008) 1.18
Iodine-131-metaiodobenzylguanidine as initial induction therapy in stage 4 neuroblastoma patients over 1 year of age. Eur J Cancer (2008) 1.18
Common variants at the 19p13.1 and ZNF365 loci are associated with ER subtypes of breast cancer and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers. Cancer Epidemiol Biomarkers Prev (2012) 1.17